Adiponectin-induced improvement of insulin resistance and adiponectin itself reduce hepatic gluconeogenesis and glycogenolysis and increase the utilization of glucose and FA by skeletal muscles, resulting in lower glucose levels. Here, ADIPOQ is linked to Insulin resistance.